Synthesis of bioactive Mercury-Picrate Analogue: Synthesis, Characterization, and Biomedical Applications

Marwa Javaid, M. Atif, Ali Imran Mallhi, Yasira Saeed, Maryam Aslam, Faisal Mahmood, Mazhar Mehmood, M. AfzalJournal of Medical & Health Sciences Review 2025 · DOI

Abstract

Synthesis, characterization, and biomedical applications of mercury complexes stabilized by multinuclear aromatic compounds are investigated in this study. Through the use of sulfur-rich and aromatic ligand frameworks, mercury complexes with increased stability, bioactivity, and imaging capabilities were developed. Successful complexation was confirmed via comprehensive analyses including spectroscopic and structural characterization. In biological evaluations, high antibacterial activity against multidrug-resistant strains and potent anticancer effects were observed for the Hg analogs, with Hg-An-3 being the most selective and efficacious. Finally, the complexes proved to be promising as agents for MRI contrast, characterized by high relaxivity and specificity. Nevertheless, toxicity evaluations suggested difficulties associated with systemic toxicity and hemolytic effects that require future optimization of ligand design and biocompatibility.

Introduction

Mercury possesses unique electronic properties and a high electron affinity that make it a compelling candidate for medicinal chemistry, despite its well-known environmental toxicity. The primary challenge in utilizing mercury therapeutically lies in "taming" the metal—developing stable chemical complexes that harness its biological activity while minimizing off-target effects. This study explores the synthesis of mercury(II) complexes wrapped in multinuclear aromatic and sulfur-rich ligand frameworks to serve as "theranostic" agents, capable of simultaneous therapy and diagnostic imaging.

Methodology

The research focused on the synthesis and evaluation of three specific mercury(II) complexes: Hg-Py-1, Hg-Ph-2, and Hg-An-3.

Synthesis and Characterization

Mercury(II) chloride ($HgCl_2$) was reacted with various ligands, including pyridine derivatives and sulfur-containing macrocycles, via reflux in ethanol and acetonitrile. Coordination was confirmed using UV-Vis and FTIR spectroscopy. High-performance liquid chromatography (HPLC) ensured a purity level exceeding 96% for all compounds, with yields ranging from 78% to 84%.

Biological and Imaging Assays

  • Antibacterial Activity: Minimum Inhibitory Concentrations (MIC) were determined against Gram-positive (S. aureus, MRSA) and Gram-negative (E. coli, P. aeruginosa) bacteria using broth microdilution.
  • Cytotoxicity: The MTT assay evaluated the complexes' efficacy against cancer cell lines (HeLa, MCF-7, A549) compared to normal 3T3-L1 mouse fibroblasts.
  • Mechanism of Action: Intracellular Reactive Oxygen Species (ROS) generation and mitochondrial disruption were monitored to determine the pathway of cell death.
  • MRI Contrast: Relaxivity ($r_1$) was measured using a 3.0 T MRI scanner to assess diagnostic potential.

Results and Discussion

Among the tested analogs, Hg-An-3 emerged as the most potent candidate across all metrics, demonstrating the importance of sulfur-rich macrocyclic ligands in stabilizing the mercury center and extending its biological lifetime.

Therapeutic Efficacy

Hg-An-3 demonstrated significant anticancer potency, with $IC_{50}$ values between 4.3 and 5.1 $\mu M$ across all tested cancer lines. In antibacterial tests, it achieved an MIC of 1 $\mu g/mL$ against Methicillin-resistant Staphylococcus aureus (MRSA), highlighting its potential against multidrug-resistant pathogens. The mechanism of action involves the induction of oxidative stress via ROS production, leading to mitochondrial failure in tumors and membrane destruction in bacteria.

Diagnostic Performance

As a contrast agent, Hg-An-3 exhibited a relaxivity ($r_1$) of 6.2 $mM^{-1}s^{-1}$ and a signal enhancement of 81%. These values suggest that the complex outperforms several standard clinical contrast agents, supporting its role in a theranostic framework where drug delivery and effectiveness can be monitored in real-time.

Conclusion and Future Directions

This research highlights the dual therapeutic and diagnostic potential of mercury-based complexes. While Hg-An-3 shows promise as a potent anticancer and antibacterial agent with high MRI specificity, systemic toxicity and hemolytic effects remain significant barriers to clinical translation. Future work must focus on ligand optimization and the development of biocompatible "stealth" coatings (such as albumin or nanoparticles) to shield the mercury complex from healthy tissues until it reaches its target. Subsequent in vivo testing is required to validate these findings in complex living systems.

Summary updated

Abstract

Synthesis, characterization, and biomedical applications of mercury complexes stabilized by multinuclear aromatic compounds are investigated in this study. Through use of sulfur rich and aromatic ligand frameworks mercury complexes with increased stability, bioactivity and imaging capabilities were developed. Successful complexation was confirmed via comprehensive analyses including spectroscopic and structural characterization, and because these complexes are robust physicochemical properties, we successfully formed complexes. In biological evaluations, we discovered high antibacterial activity against multidrug resistance strains and potent anticancer effects for the Hg analogs, with Hg-An-3 being the most selective and efficacious. Finally, the complexes proved to be promising as agents for MRI contrast, characterized by high relativity and specificity for subsequent diagnostic imaging. Nevertheless, toxicity evaluations suggested difficulties associated with systemic toxicity and hemolytic effects that require future optimization of ligand design and biocompatibility. The dual therapeutic and diagnostic potential of mercury complexes highlighted by this research should be followed by addressing toxicity if the mercury complexes are to be clinically translated. These findings will help in the development of other interdisciplinary efforts to design efficient mercury based theranostic agents.
BibTeX
@article{javaid2025synthesis,
  author = {Marwa Javaid and M. Atif and Ali Imran Mallhi and Yasira Saeed and Maryam Aslam and Faisal Mahmood and Mazhar Mehmood and M. Afzal},
  title = {{Synthesis of bioactive Mercury-Picrate Analogue: Synthesis, Characterization, and Biomedical Applications}},
  journal = {Journal of medical \& health sciences review.},
  year = {2025},
  doi = {10.62019/3cpgr654},
}
Figure